Soumya Eswaran
Thu, May 8, 2025, 6:08 AM 3 min read
In This Article:
Baron Funds, an concern absorption firm, released its “Focused Growth Fund” archetypal 4th 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Q1 was a hard commencement to the year. The money declined 7.95% (Institutional Shares) successful the quarter, compared to the Russell 2500 Growth Index’s (the Benchmark) 10.80% return. Please spare immoderate clip to cheque the fund’s apical 5 holdings to cognize much astir their apical bets for 2025.
In its first-quarter 2025 capitalist letter, Baron Focused Growth Fund highlighted stocks specified arsenic IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures, and distributes products chiefly for the companion carnal veterinary, livestock and poultry, dairy, and h2o investigating markets. The one-month instrumentality of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was 27.44%, and its shares mislaid 2.84% of their worth implicit the past 52 weeks. On May 7, 2025, IDEXX Laboratories, Inc. (NASDAQ:IDXX) banal closed astatine $486.61 per stock with a marketplace capitalization of $39.134 billion.
Baron Focused Growth Fund stated the pursuing regarding IDEXX Laboratories, Inc. (NASDAQ:IDXX) successful its Q1 2025 capitalist letter:
"The show of galore stocks successful the Health Care assemblage tin alteration rapidly owed to exogenous events oregon binary outcomes (e.g., biotechnology and pharmaceuticals). As a result, we bash not put a ample magnitude successful these stocks successful this focused portfolio. In Health Care, we put successful competitively advantaged companies that are leaders successful their industries specified arsenic IDEXX Laboratories, Inc. (NASDAQ:IDXX), the starring supplier of diagnostics to the veterinary manufacture and who is benefiting from the summation successful pets that radical acquired during the COVID pandemic, particularly arsenic these pets age. The Fund is further diversified by investments successful businesses astatine antithetic stages of maturation and development."
A veterinarian successful a veterinary session examining a companion animal.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 58 hedge money portfolios held IDEXX Laboratories, Inc. (NASDAQ:IDXX) astatine the extremity of the 4th fourth which was 42 successful the erstwhile quarter. In the archetypal 4th of 2025, IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported integrated gross maturation of 5% driven by 4.5% integrated gross gains successful the CAG business, 7% integrated maturation successful water, and 4% integrated maturation successful LPD. While we admit the imaginable of IDEXX Laboratories, Inc. (NASDAQ:IDXX) arsenic an investment, our condemnation lies successful the content that AI stocks clasp greater committedness for delivering higher returns, and doing truthful wrong a shorter timeframe. If you are looking for an AI banal that is arsenic promising arsenic NVIDIA but that trades astatine little than 5 times its earnings, cheque retired our study astir the cheapest AI stock.